MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0010793
Frankfurt Pharmaceuticals Private Limited
Frankfurt Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.87 Cr
▲ 10% YoY
Net profit · FY 2025
₹1.71 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹6.9 Lakh
EBITDA margin 3.7%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
22 yrs
Est. 2004
Employees · EPFO
15
Provident fund records
Directors on board
3
As per MCA filings
About Frankfurt Pharmaceuticals Private Limited
Data last updated:
Frankfurt Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC127496. Its GSTIN is 07AAACF8199C1ZJ (Delhi).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rakesh Raina and Manish Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Space No. 6 (Basement) Vikram Tower 16 Rajindra Place, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.87 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.71 Lakh (net margin 0.9%) and EBITDA of ₹6.9 Lakh (EBITDA margin 3.7%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 5% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
Frankfurt Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0010793). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2004PTC127496
Registration Number 127496
Incorporation Date 09 July 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0010793
Recognitions & Rankings of Frankfurt Pharmaceuticals
Contact details
Frankfurt Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressSpace No. 6 (Basement) Vikram Tower 16 Rajindra Place, New Delhi, Delhi, India – 110060
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Frankfurt Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Frankfurt Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Financials of Frankfurt Pharmaceuticals Private Limited
FY 2025 filings availableFrankfurt Pharmaceuticals Private Limited reported revenue of ₹1.87 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹1.87 Cr ▲ 10%
Net profit · FY 2025
₹1.71 Lakh margin 0.9%
EBITDA · FY 2025
₹6.9 Lakh margin 3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 5%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 94%
3 years · compounded
▲ 38%
5 years · compounded
▲ 7%
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Frankfurt Pharmaceuticals Private Limited
Frankfurt Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Raina | Director | 19 Jul 2004 | 22 Years 3 Months | Current |
| Manish Sharma | Director | 19 Jul 2004 | 22 Years 3 Months | Current |
| Sunil Kumar Bhat | Director | 19 Jul 2004 | 22 Years 3 Months | Current |
Peer comparison
Frankfurt Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pashupati Chemicals & Pharmaceuticals Limited | ₹1.87 Cr (FY 2024) | -23.0% | Kolkata, West Bengal, India | |||
| Frankfurt Pharmaceuticals Private Limitedthis company | ₹1.87 Cr (FY 2025) | ₹1.71 Lakh | 0.9% | 10.0% | 15 | New Delhi, Delhi, India |
| Astorion Pharmaceuticals Private Limited | ₹1.87 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Nexa Healthcare Private Limited | ₹1.87 Cr (FY 2024) | 3.0% | Meerut, Uttar Pradesh, India | |||
| Ubix Bioscience Private Limited | ₹1.86 Cr (FY 2024) | 24.0% | Uttarakhand, India |
To see the full peer comparison of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Auditor
Frankfurt Pharmaceuticals Private Limited is audited by UDIT RASTOGI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UDIT RASTOGI AND ASSOCIATES | FY 2023 | 521989 |
Shareholding
The shareholding of Frankfurt Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Frankfurt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Frankfurt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Frankfurt Pharmaceuticals Private Limited has a workforce of 15 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
-11.76%
GST
Frankfurt Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACF8199C1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Frankfurt Pharmaceuticals Private Limited, buy the company report.
Recent activity
Frankfurt Pharmaceuticals Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Jatin Sakhuja ceased to be Director on 29 Apr 2023.
AGM
Frankfurt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Frankfurt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Jatin Sakhuja ceased to be Director.
Appointed
Manish Sharma was appointed as Director.
Appointed
Rakesh Raina was appointed as Director.
Appointed
Sunil Kumar Bhat was appointed as Director.
Incorporation
09 Jul 2004
Frankfurt Pharmaceuticals Private Limited was registered on 09 Jul 2004 with Roc Delhi Ii & aged 22 years 4 months as per MCA records.
Frequently asked questions
Frankfurt Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 2004 (22+ years old) and is registered under CIN U24232DL2004PTC127496.
Frankfurt Pharmaceuticals has 3 current directors:
- Rakesh Raina - Director
- Manish Sharma - Director
- Sunil Kumar Bhat - Director
The latest financial statements of Frankfurt Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Frankfurt Pharmaceuticals is 07AAACF8199C1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Frankfurt Pharmaceuticals is U24232DL2004PTC127496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Frankfurt Pharmaceuticals was incorporated on 09 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Frankfurt Pharmaceuticals by revenue are Pashupati Chemicals & Pharmaceuticals Limited, Astorion Pharmaceuticals Private Limited, Nexa Healthcare Private Limited, Ubix Bioscience Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Jatin Sakhuja ceased to be Director on 29 Apr 2023. Manish Sharma was appointed as Director on 19 Jul 2004. Rakesh Raina was appointed as Director on 19 Jul 2004. Frankfurt Pharmaceuticals has 4 board changes on record in total.
Yes, Frankfurt Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0010793).
The registered office of Frankfurt Pharmaceuticals is at Space No. 6 Basement Vikram Tower 16 Rajindra Place, New Delhi, Delhi, India – 110060.
Frankfurt Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages